| Normal (n = 46) | Obese (n = 18) | Sarcopenia (n = 35) | Sarcopenic obesity (n = 18) | p value |
---|---|---|---|---|---|
Age, years | 60 ± 12 | 62 ± 12 | 70 ± 12 †| 67 ± 9 | 0.002 |
Female, n (%) | 11 (24) | 8 (44) | 12 (34) | 10 (56) | 0.088 |
BMI, kg/m2 | 23.6 ± 3.5 | 27.1 ± 5.8 †| 20.8 ± 2.8 †| 26.3 ± 4.6 †§ | < 0.001 |
HD vintage, years | 7 ± 5 | 8 ± 5 | 7 ± 7 | 5 ± 5 | 0.535 |
Comorbidity | |||||
Hypertension, n (%) | 45 (98%) | 18 (100%) | 33 (94%) | 15 (83%) | 0.080 |
Dyslipidemia, n (%) | 15 (33%) | 3 (17%) | 8 (24%) | 6 (33%) | 0.525 |
Diabetes mellitus, n (%) | 24 (52%) | 11 (61%) | 16 (46%) | 14 (78%) | 0.144 |
Laboratory data | |||||
Hb, g/dL | 10.5 ± 1.1 | 10.4 ± 1.1 | 10.4 ± 1.4 | 10.6 ± 1.0 | 0.921 |
sCr, mg/dL | 11.7 ± 2.7 | 11.9 ± 2.2 | 9.9 ± 2.5 †‡ | 9.5 ± 2.5 †‡ | 0.001 |
BUN, g/dL | 63.2 ± 15.5 | 62.4 ± 14.8 | 55.8 ± 17.8 | 58.8 ± 14.6 | 0.209 |
Alb, mg/dL | 3.7 ± 0.3 | 3.8 ± 0.3 | 3.6 ± 0.3 | 3.7 ± 0.3 | 0.093 |
P, pg/dL | 5.8 ± 1.3 | 5.8 ± 1.2 | 5.4 ± 1.2 | 5.5 ± 1.6 | 0.497 |
Ca, mg/dL | 8.9 ± 0.7 | 8.8 ± 0.9 | 8.7 ± 0.7 | 8.8 ± 0.8 | 0.721 |
K, mg/dL | 4.9 ± 0.8 | 5.1 ± 0.5 | 4.8 ± 0.7 | 5.1 ± 0.7 | 0.425 |
CRP, mg/dL | 0.5 ± 1.2 | 0.3 ± 0.3 | 0.4 ± 0.7 | 0.9 ± 2.3 | 0.463 |
KT/V | 1.3 ± 0.2 | 1.4 ± 0.2 | 1.3 ± 0.3 | 1.3 ± 0.3 | 0.809 |
nPNA, g/kg/day | 0.9 ± 0.2 | 0.9 ± 0.2 | 0.8 ± 0.2 | 0.8 ± 0.2 | 0.558 |
MNA-SF, points | 12.5 ± 1.9 | 13.2 ± 1.3 | 11.6 ± 1.7 ‡ | 12.6 ± 1.8 | 0.008 |
EAT-10, points | 1.3 ± 3.6 | 0.4 ± 1.1 | 1.5 ± 4.1 | 0.6 ± 1.4 | 0.619 |
SNAQ, points | 14.6 ± 2.7 | 14.7 ± 1.7 | 14.4 ± 2.5 | 15.1 ± 1.3 | 0.795 |
% Fat mass, % | 18.8 ± 8.5 | 37.8 ± 5.3 †| 22.2 ± 4.7 ‡ | 38.1 ± 5.9 †§ | < 0.001 |
Skeletal muscle mass index, kg/m2 | 7.6 ± 5.1 | 4.0 ± 1.2 †| 3.3 ± 0.9 †| 3.2 ± 0.7 †| < 0.001 |
Muscle wasting, n (%) | 26 (68%) | 17 (94%) | 35 (100%) | 18 (100%) | < 0.001 |